Jump To: 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019
2026 Technical Bulletins
New Gram Positive Cocci Susceptibility Panels
View →New Chemistry & Immunology Instrumentation and Reference Ranges
View →Update to Coagulation reference ranges (BNP)
View →Update to Coagulation reference ranges (TnI)
View →Discontinuation of Respiratory syncytial virus (RSV) Antigen testing
View →Respiratory Disease (Influenza AB, COVID-19 & RSV) NAAT Testing Updates
View →Clostridioides (Clostridium) difficile PCR now available at Queen’s Manamana and Queen’s West Oahu laboratories
View →Updates to PT/INR Result Reporting – Effective October 7, 2025
View →Transition to New von Willebrand, Factor Assays and Introduction of von Willebrand Activity Assay
View →BIOFIRE FILMARRAY GI Panel Update: Vibrio targets
View →NGS Oncology Tumor Profile Update - ComboMATCH Approved
View →UPDATE: Rapid Preliminary Identification from Positive Blood Culture Bottles
View →Lupus Anticoagulant Testing (dRVVT) and Introduction of Activated Protein C Resistance (APCR) Testing
View →New Chemistry & Immunology Instrumentation and Reference Ranges
View →Curian® Campy Rapid Fluorescent Immunoassay
View →Sending out Prolactin with Reflex to Monomeric Prolactin
View →Acceptable Group B Streptococcus (GBS) Source
View →UPDATE: Medical Device Recall: BIOFIRE FILMARRAY Pneumonia Panel
View →UPDATE: Medical Device Recall: BIOFIRE FILMARRAY GI Panel
View →Sending out SARS-Cov-2 Nucleocapsid Total Ab, Qualitative and SARS-Cov-2 Spike Total Ab, Semi-Quantitative Testing
View →Replacement of the Melanoma NGS Profile
View →New Gram-Negative Bacillus Susceptibility Panels
View →Outsourcing Blood Cultures for Fungi and Acid Fast Bacilli (AFB)
View →Acceptable Fecal Occult Blood Collection Devices
View →Procalcitonin Biomarker for Serious Infections – Update #1
View →Reflex test algorithms for Hepatitis B and Hepatitis C
View →Aerococcus Susceptibility to Antimicrobics
View →Rapid PCR Testing for Mycobacterium tuberculosis
View →Pyrazinamide (PZA) Testing for Mycobacterium tuberculosis
View →Sexually Transmitted Infection Testing in Young Patients
View →Legionella Testing by Urine Antigen & Legionella Culture
View →Sending Out Mitochondrial M2 Antibody Testing
View →No Longer Covered: Respiratory Panel & Stool GI Pathogen Panel
View →HCV Panels simplify compliance with Public Health recommendations
View →Discontinuation of DNA/RNA Shield Collection Media and DLS Central Testing for COVID-19 on ThermoFisher High-Throughput Platform
View →Update to HSV Serology Testing and STI Panels
View →Updated Interpretive Comments for QuantiFERON-TB Gold Plus
View →Testing for Sexually Transmitted Infections - Update
View →Testing for Sexually Transmitted Infections - Expansion
View →New Testing for Carbapenemase Genes Improves Inpatient Management
View →New Fecal Occult Blood Collection Devices
View →SARS-CoV-2 EUA Fact Sheets for Providers
View →HIV Antigen/Antibody Screen Test Provides Analyte-Specific Results
View →QuantiFeron IGRA Demonstrates Uncertainty Around the Cutoff
View →Outsourcing Ova and Parasite Test for Intestinal Parasites
View →Medicare Coverage Restriction for Combination Orders of Tumor Antigen CA 15-3 (TC 207) and CA 27.29 (TC 4659)
View →Taxonomy Changes in the MALDI-TOF/MS Database
View →Interpretation of SARS-CoV-2 (COVID-19) PCR Presumptive Positive
View →Remove race from eGFR Calculation
View →RAPIDPoint 500e Blood Gas Analyzer
View →Procalcitonin Testing available in North Hawaii
View →Suppression of Clostridioides difficile Result in Multiplex GI Panel
View →Temporary Discontinuation of VerifyNow
View →Update: Kappa and Lambda Light Chains, Free testing performed in house
View →Fecal Lactoferrin Replacing WBC-Stool (Fecal Leukocytes) to Indicate Inflammation in the Bowel
View →Discontinuation of Hemoccult Fecal Occult Blood Test
View →Updated Albumin / Globulin Ratio Reference Range
View →Tissue Oncology Testing is available in CARE*Link
View →Oncology Testing Supports QMC Precision Medicine Program
View →Discontinuation of In-house Hepatitis B envelope Ag and Ab Testing
View →Updated Kappa and Lambda Light Chains, Free
View →The VDRL Test Performed on CSF will Automatically Reflex to Provide a Titer
View →Discontinuation of Streptozyme Testing
View →Antimicrobic Susceptibility Interpretations
View →Change in Ordering Practice for Outpatient Transfusions
View →Tests Unavailable for Add-on Requests
View →Troponin T Generation 5 STAT Assay
View →Rapid Multiplex Pneumonia Panel Now Available at Central
View →Local testing for procalcitonin is available in Guam beginning December 17, 2019
View →Update on Testing for Helicobacter Pylori Infections
View →Rapid PCR replaces Antigen Testing for Influenza in Guam
View →Availability of QuantiFERON-TB Gold Plus in Guam and Saipan
View →Update for Urinalysis Result Reporting
View →Quantitative CMV testing by qPCR available at DLS Central Laboratory
View →Clostridioides (Clostridium) difficile screening now available at Queen’s Punchbowl and Queen’s West Oahu laboratories
View →New Bood Culture Instruments and Bottles
View →Updated Fluoroquinolone Susceptibility Interpretation
View →Genotyping for HIV Drug Resistance now includes Integrase Inhibitors
View →Routine and Special Circumstance use of Throat Culture
View →Next Generation Hepatitis B Surface Antigen Assay
View →Pneumococcus Testing by Rapid Antigen Compliments Laboratory Approach to Community-Acquired Pneumonia (CAP) and Meningitis
View →Update to Protime INR reporting range
View →Reflex test algorithms for Hepatitis B and Hepatitis C
View →
